The GI Quality Improvement Consortium (GIQuIC) is a benchmarking clinical registry
developed in collaboration with the ACG and ASGE. This registry prospectively collects
colonoscopy data including pathology, providing the opportunity for benchmarking and
quality improvement. The adenoma detection rate (ADR) is the proportion of individuals
undergoing a complete screening colonoscopy who have one or more adenomas detected.
Higher ADRs have been inversely correlated with interval colorectal cancer risk. The
recommended benchmarks for ADR on screening colonoscopy have been 15% in women and
25% in men but has recently been increased to 20% and 30% respectively. GIQUIC includes
over 4,000 physicians and 3,500,000 colonoscopies and provides an opportunity to assess
overall ADRs and ADR trends in a large group of endoscopists.
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Gastrointestinal EndoscopyAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
Article info
Identification
Copyright
© 2017 Published by Elsevier Inc.
